Volitionrx Total Assets from 2010 to 2024

VNRX Stock

USD 0.69 0.01 1.43%

Volitionrx Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2004-09-30

Previous Quarter

13.1 M

Current Value

12.7 M

Quarterly Volatility

11.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 232.7 K, Other Operating Expenses of 38.6 M or Total Operating Expenses of 38.6 M, as well as many indicators such as Price To Sales Ratio of 62.58, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.

Check out the analysis of Volitionrx Correlation against competitors.

For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Latest Volitionrx's Total Assets Growth Pattern

Below is the plot of the Total Assets of Volitionrx over the last few years. Total assets refers to the total amount of Volitionrx assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Volitionrx books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Volitionrx's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 27.95 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Volitionrx Total Assets Regression Statistics

	Arithmetic Mean	15,003,307
	Geometric Mean	4,958,869
	Coefficient Of Variation	73.68
	Mean Deviation	9,696,138
	Median	17,488,966
	Standard Deviation	11,053,748
	Sample Variance	122.2T
	Range	29.3M
	R-Value	0.91
	Mean Square Error	22.6T
	R-Squared	0.83
	Slope	2,249,302
	Total Sum of Squares	1710.6T

Volitionrx Total Assets History

	2024	29.3 M
	2023	28 M
	2022	18.3 M
	2021	27.5 M
	2020	26.2 M
	2019	21.3 M
	2018	17.5 M

Other Fundumenentals of Volitionrx

Intangibles To Total Assets

Volitionrx Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Intangible Assets	Property Plant Equipment	Short Term Debt	Net Tangible Assets	Current Deferred Revenue	Capital Surpluse	Short Long Term Debt	Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock	Net Receivables
Total Assets		0.3	-0.94	-0.85	0.64	0.68	0.99	0.88	-0.89	0.92	0.81	0.44	0.51	0.9	-0.61	0.81	0.86	-0.17	-0.27	0.67	0.52
Total Stockholder Equity	0.3		-0.51	0.19	-0.48	-0.49	0.36	-0.17	-0.11	0.03	-0.2	0.99	-0.65	-0.07	-0.65	-0.02	0.24	0.8	0.77	-0.38	-0.62
Net Debt	-0.94	-0.51		0.65	-0.4	-0.47	-0.97	-0.69	0.77	-0.74	-0.58	-0.64	-0.31	-0.72	0.72	-0.63	-0.73	-0.01	0.07	-0.48	-0.34
Retained Earnings	-0.85	0.19	0.65		-0.92	-0.92	-0.8	-0.99	0.89	-0.96	-0.99	0.05	-0.79	-0.99	0.25	-0.92	-0.82	0.51	0.62	-0.91	-0.77
Accounts Payable	0.64	-0.48	-0.4	-0.92		0.95	0.57	0.91	-0.74	0.81	0.91	-0.37	0.89	0.88	0.0	0.77	0.58	-0.7	-0.79	0.9	0.85
Total Liab	0.68	-0.49	-0.47	-0.92	0.95		0.63	0.93	-0.72	0.81	0.89	-0.35	0.97	0.87	-0.06	0.76	0.6	-0.77	-0.84	0.9	0.96
Total Current Assets	0.99	0.36	-0.97	-0.8	0.57	0.63		0.83	-0.86	0.87	0.75	0.5	0.47	0.85	-0.65	0.76	0.83	-0.13	-0.22	0.62	0.49
Common Stock	0.88	-0.17	-0.69	-0.99	0.91	0.93	0.83		-0.89	0.95	0.96	-0.03	0.81	0.98	-0.3	0.89	0.81	-0.51	-0.62	0.88	0.81
Intangible Assets	-0.89	-0.11	0.77	0.89	-0.74	-0.72	-0.86	-0.89		-0.91	-0.86	-0.24	-0.56	-0.9	0.55	-0.84	-0.85	0.29	0.39	-0.7	-0.55
Property Plant Equipment	0.92	0.03	-0.74	-0.96	0.81	0.81	0.87	0.95	-0.91		0.95	0.17	0.65	0.98	-0.4	0.93	0.9	-0.33	-0.44	0.8	0.64
Short Term Debt	0.81	-0.2	-0.58	-0.99	0.91	0.89	0.75	0.96	-0.86	0.95		-0.07	0.75	0.98	-0.19	0.93	0.83	-0.47	-0.58	0.87	0.73
Net Tangible Assets	0.44	0.99	-0.64	0.05	-0.37	-0.35	0.5	-0.03	-0.24	0.17	-0.07		-0.52	0.07	-0.71	0.09	0.35	0.72	0.69	-0.26	-0.48
Current Deferred Revenue	0.51	-0.65	-0.31	-0.79	0.89	0.97	0.47	0.81	-0.56	0.65	0.75	-0.52		0.72	0.05	0.59	0.41	-0.88	-0.93	0.84	0.99
Capital Surpluse	0.9	-0.07	-0.72	-0.99	0.88	0.87	0.85	0.98	-0.9	0.98	0.98	0.07	0.72		-0.33	0.92	0.85	-0.41	-0.52	0.86	0.71
Short Long Term Debt	-0.61	-0.65	0.72	0.25	0.0	-0.06	-0.65	-0.3	0.55	-0.4	-0.19	-0.71	0.05	-0.33		-0.25	-0.49	-0.16	-0.14	0.03	0.04
Long Term Debt	0.81	-0.02	-0.63	-0.92	0.77	0.76	0.76	0.89	-0.84	0.93	0.93	0.09	0.59	0.92	-0.25		0.93	-0.29	-0.4	0.84	0.58
Long Term Debt Total	0.86	0.24	-0.73	-0.82	0.58	0.6	0.83	0.81	-0.85	0.9	0.83	0.35	0.41	0.85	-0.49	0.93		-0.11	-0.2	0.63	0.4
Net Invested Capital	-0.17	0.8	-0.01	0.51	-0.7	-0.77	-0.13	-0.51	0.29	-0.33	-0.47	0.72	-0.88	-0.41	-0.16	-0.29	-0.11		0.99	-0.6	-0.85
Net Working Capital	-0.27	0.77	0.07	0.62	-0.79	-0.84	-0.22	-0.62	0.39	-0.44	-0.58	0.69	-0.93	-0.52	-0.14	-0.4	-0.2	0.99		-0.7	-0.89
Capital Stock	0.67	-0.38	-0.48	-0.91	0.9	0.9	0.62	0.88	-0.7	0.8	0.87	-0.26	0.84	0.86	0.03	0.84	0.63	-0.6	-0.7		0.83
Net Receivables	0.52	-0.62	-0.34	-0.77	0.85	0.96	0.49	0.81	-0.55	0.64	0.73	-0.48	0.99	0.71	0.04	0.58	0.4	-0.85	-0.89	0.83

Click cells to compare fundamentals

About Volitionrx Financial Statements

Volitionrx investors use historical fundamental indicators, such as Volitionrx's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	28 M	29.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC